Monsanto Company and TargetGene Biotechnologies LTD, a pioneer in genome-editing technologies, have announced a license agreement to advance the application of the company’s proprietary techniques in global agriculture.
TargetGene is an innovative genome-editing company using RNA-guided gene-editing techniques. In addition, Monsanto and Nomad Bioscience GmbH announced a licensing agreement whereby Monsanto has obtained rights to apply Nomad’s proprietary technology to its genome-editing projects aimed at enhancement of agricultural crops.
Under the agreement with TargetGene, Monsanto has been granted an exclusive license to TargetGene’s novel and proprietary "T∙GEE" (Genome Editing Engine) platform to deliver continuous improvements in agriculture. Monsanto has also established an equity position in the private Israel-based company. Additional terms of the agreement were not disclosed.
Source: www.agprofessional.com